DXRX Diaceutics Plc

TIDMDXRX

Diaceutics PLC

07 September 2023

Diaceutics to attend 10(th) Annual HealthTech Investment Forum in Basel on September 19

Belfast and London, 7 September 2023 - Diaceutics PLC (AIM: DXRX) , a leading technology and solutions provider to the pharmaceutical industry, announces that management will attend and present at the 10 (th) Annual HealthTech Investment Forum in Basel, Switzerland on 19 September, 2023. Diaceutics CEO Peter Keeling will be a

speaker at the   Revolution in Precision Medicine Panel: Investing in Big Data & AI . 

For more information, please click here .

Enquiries:

 
Diaceutics PLC                                   Tel: +44 (0)28 9040 6500 
Peter Keeling, Chief Executive Officer   investorrelations@diaceutics.com 
 Ryan Keeling, Chief Innovation Officer 
 Nick Roberts, Chief Financial Officer 
 
 
Stifel Nicolaus Europe Limited (Nomad            Tel: +44 (0)20 7710 7600 
 & Broker) 
Ben Maddison 
Nick Harland 
 Kate Hanshaw 
 
 
Alma PR                                          Tel: +44 (0)20 3405 0205 
Caroline Forde                                    diaceutics@almapr.co.uk 
Matthew Young 
Kinvara Verdon 
 

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostic Network(R).

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFLFFEALIEIIV

(END) Dow Jones Newswires

September 07, 2023 02:00 ET (06:00 GMT)

Diaceutics (LSE:DXRX)
Historical Stock Chart
From Apr 2024 to May 2024

Diaceutics (LSE:DXRX)
Historical Stock Chart
From May 2023 to May 2024